Cancer Research

Four-plex detection of biomarker and checkpoint markers in FFPE in cervical cancer tissues stained with RNAscope™ Multiplex Fluorescent Assay v2 and RNAscope™ 4-Plex Ancillary Kit: KRT19 (green), CD8A (yellow), CD4 (red), CD68 (white).

Four-plex detection of biomarker and checkpoint markers in FFPE in cervical cancer tissues stained with RNAscope™ Multiplex Fluorescent Assay v2 and RNAscope™ 4-Plex Ancillary Kit: KRT19 (green), CD8A (yellow), CD4 (red), CD68 (white).

Four-plex detection of biomarker and checkpoint markers in FFPE lung cancer tissues stained with RNAscope™ Multiplex Fluorescent Assay v2 and RNAscope™ 4-Plex Ancillary Kit: KRT19 (green), CD8A (yellow), CD4 (red), CD68 (white).

Four-plex detection of biomarker and checkpoint markers in FFPE lung cancer tissues stained with RNAscope™ Multiplex Fluorescent Assay v2 and RNAscope™ 4-Plex Ancillary Kit: KRT19 (green), CD8A (yellow), CD4 (red), CD68 (white).

Expression of HOTAIR in human breast cancer tissue using RNAscope™ 2.5 HD Assay Brown RNA in situ hybridization (ISH)

Expression of HOTAIR in human breast cancer tissue using RNAscope™ 2.5 HD Assay Brown

Expression of PCA3 in human prostate cancer tissue using RNAscope™ 2.5 HD Assay Brown RNA in situ hybridization (ISH)

Expression of PCA3 in human prostate cancer tissue using RNAscope™ 2.5 HD Assay Brown

Expression of EGFR RNA (red dots) in human breast cancer FFPE tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

Expression of EGFR RNA (red dots) in human breast cancer FFPE tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

Expression of CD274 RNA (brown dots) in human breast cancer FFPE tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of CD274 RNA (brown dots) in human breast cancer FFPE tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of ANXA10 RNA (brown dots) in human bladder cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of ANXA10 RNA (brown dots) in human bladder cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of BAP1 RNA (brown dots) in human bladder cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of BAP1 RNA (brown dots) in human bladder cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of ERBB3 RNA (brown dots) in human bladder cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of ERBB3 RNA (brown dots) in human bladder cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of FGFR3 RNA (brown dots) in human bladder cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of FGFR3 RNA (brown dots) in human bladder cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of GATA3 RNA (brown dots) in human bladder cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of GATA3 RNA (brown dots) in human bladder cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of SPP1 RNA (brown dots) in human bladder cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of SPP1 RNA (brown dots) in human bladder cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of TACC3 RNA (brown dots) in human bladder cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of TACC3 RNA (brown dots) in human bladder cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of ERBB3 RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of ERBB3 RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of FGFR1 RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of FGFR1 RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of GATA3 RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of GATA3 RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of IGF2 RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of IGF2 RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of IL6 RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of IL6 RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of RRM1 RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of RRM1 RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of S100P RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of S100P RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of SPP1 RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of SPP1 RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of TACC3 RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of TACC3 RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of BRCA1 RNA (red dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

Expression of BRCA1 RNA (red dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

Expression of CCND1 RNA (red dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

Expression of CCND1 RNA (red dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

Expression of PGR RNA (red dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

Expression of PGR RNA (red dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

Expression of TP63 RNA (red dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

Expression of TP63 RNA (red dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

Expression of FGF2 RNA (red dots) in human colorectal cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

Expression of FGF2 RNA (red dots) in human colorectal cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

Expression of IL6 RNA (red dots) in human colorectal cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

Expression of IL6 RNA (red dots) in human colorectal cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

Expression of MMP9 RNA (red dots) in human colorectal cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

Expression of MMP9 RNA (red dots) in human colorectal cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

Expression of SHH RNA (red dots) in human colorectal cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

Expression of SHH RNA (red dots) in human colorectal cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

Expression of EGFR RNA (red dots) in human lung cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

Expression of EGFR RNA (red dots) in human lung cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

Expression of ERBB3 RNA (red dots) in human lung cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

Expression of ERBB3 RNA (red dots) in human lung cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

Expression of IL6 RNA (red dots) in human lung cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

Expression of IL6 RNA (red dots) in human lung cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

Expression of MMP9 RNA (red dots) in human lung cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

Expression of MMP9 RNA (red dots) in human lung cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

Expression of NRG1 RNA (red dots) in human lung cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

Expression of NRG1 RNA (red dots) in human lung cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

Expression of KIT RNA (red dots) in human melanoma tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

Expression of KIT RNA (red dots) in human melanoma tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

Expression of TP63 RNA (red dots) in human prostate cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

Expression of TP63 RNA (red dots) in human prostate cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

HPV expression in human head and neck cancer cancer tissue, RNA in situ hybridization (ISH) using automated RNAscope™ Ventana Assay - BROWN

HPV expression in human head and neck cancer cancer tissue, RNA in situ hybridization (ISH) using automated RNAscope™ Ventana Assay - BROWN

Expression of DLL4 RNA (brown dots) in human colorectal cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of DLL4 RNA (brown dots) in human colorectal cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of HGF RNA (brown dots) in human colorectal cancer tissue, RNA in situ hybridization (ISH) using automated RNAscope™ Leica Assay-BROWN

Expression of HGF RNA (brown dots) in human colorectal cancer tissue, RNA in situ hybridization (ISH) using automated RNAscope™ Leica Assay-BROWN

Expression of PDL1 RNA (brown dots) in human colorectal cancer tissue, RNA in situ hybridization (ISH) using automated RNAscope™ Leica Assay-BROWN

Expression of PDL1 RNA (brown dots) in human colorectal cancer tissue, RNA in situ hybridization (ISH) using automated RNAscope™ Leica Assay-BROWN

Expression of IGF2 RNA (brown dots) in human esophageal cancer tissue, RNA in situ hybridization (ISH) using automated RNAscope™ Leica Assay-BROWN

Expression of IGF2 RNA (brown dots) in human esophageal cancer tissue, RNA in situ hybridization (ISH) using automated RNAscope™ Leica Assay-BROWN

Expression of IGF1 RNA (brown dots) in human lung cancer tissue, RNA in situ hybridization (ISH) using automated RNAscope™ Leica Assay-BROWN

Expression of IGF1 RNA (brown dots) in human lung cancer tissue, RNA in situ hybridization (ISH) using automated RNAscope™ Leica Assay-BROWN

Expression of PDL1 RNA (brown dots) in human lung cancer tissue, RNA in situ hybridization (ISH) using automated RNAscope™ Leica Assay-BROWN

Expression of PDL1 RNA (brown dots) in human lung cancer tissue, RNA in situ hybridization (ISH) using automated RNAscope™ Leica Assay-BROWN

Expression of CD19 RNA (red dots) in human lymphoma tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

Expression of CD19 RNA (red dots) in human lymphoma tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

CD274 mRNA expression in human cervical cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

CD274 mRNA expression in human cervical cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

CD274 mRNA expression in human colorectal cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

CD274 mRNA expression in human colorectal cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

CD274 mRNA expression in human non-small lung cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

CD274 mRNA expression in human non-small lung cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-RED

CD274 mRNA expression in human renal cell carcinoma tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

CD274 mRNA expression in human renal cell carcinoma tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of EGFR RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of EGFR RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of ERBB3 RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of ERBB3 RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of FGFR1 RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of FGFR1 RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of HER2 RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of HER2 RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of IL6 RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of IL6 RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of LOXL2 RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of LOXL2 RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of MMP9 RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of MMP9 RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of NRG1 RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of NRG1 RNA (brown dots) in human breast cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of IDH2 RNA (brown dots) in human colorectal cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of IDH2 RNA (brown dots) in human colorectal cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of LGR5 RNA (brown dots) in human colorectal cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of LGR5 RNA (brown dots) in human colorectal cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of LOXL2 RNA (brown dots) in human colorectal cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of LOXL2 RNA (brown dots) in human colorectal cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of SHH RNA (brown dots) in human colorectal cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of SHH RNA (brown dots) in human colorectal cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of AREG RNA (brown dots) in human lung cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of AREG RNA (brown dots) in human lung cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of EREG RNA (brown dots) in human lung cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of EREG RNA (brown dots) in human lung cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of FGFR1 RNA (brown dots) in human ovarian cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of FGFR1 RNA (brown dots) in human ovarian cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of VEGFR2 RNA (brown dots) in human renal cell cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

Expression of VEGFR2 RNA (brown dots) in human renal cell cancer tissue, RNA in situ hybridization (ISH) using RNAscope™ 2.0 HD Reagent Kit-BROWN

A tumor is a complex organ consisting of many cell types. Localization of an alteration in gene expression to specific cell types provides the first link to cellular function. The pursuit of personalized medicine through technologies like microarrays and next-generation sequencing has generated a wealth of novel biomarkers, which promise to improve cancer diagnosis and patient stratification. However, for many of these biomarkers, we do not know which specific cell types in the tumor express them. This limits our ability to fully understand their biological relevance. Furthermore, clinically relevant changes in gene expression in specific cell types may be lost in RNA extraction-based methods such as microarrays and RT-PCR.

Application Review

Here we summarize the role of novel RNA in situ hybridization technology in expanding the tool-set available to researchers, thereby overcoming the challenges of cancer research in four key areas:

  1. Analysis of gene expression to understand tumor heterogeneity
  2. Studying non-coding RNAs
  3. Developing biomarkers
  4. Driving and refining the diagnostic strategies of the future

Visualizing the Cancer Transcriptome - How RNA in situ Hybridization Offers an Essential Data Dimension in Cancer Research

Researchers in the Spotlight

In our Researcher in the Spotlight Section you can learn from key researchers about their use of RNAscope technology and how this helps them to advance their research in unique ways by adding morphological context to RNA expression analysis.

Interview with Dr Rohit Mehra:
"Realising the potential of Iong noncoding RNA as a cancer biomarker - From NGS discovery to validation with RNA in situ Hybridization"

Interview with Dr Nallasivam Palanisamy:
"Development of Prostate Cancer Personalized Medicine - Advancing analysis of prostate tumor molecular heterogeneity by combined immunohistochemistry and novel RNA in situ hybridization"

Related Publications

Publications using RNAscope in situ Technology in Cancer Research Applications

There are now more than 330 Cancer Research publications citing for RNAscope technology - Please download our latest Cancer/ HPV specific publication list here:

X
Contact Us

Complete one of the three forms below and we will get back to you.

For Quote Requests, please provide more details in the Contact Sales form below

Advanced Cell Diagnostics

Our new headquarters office starting May 2016:

7707 Gateway Blvd.  
Newark, CA 94560
Toll Free: 1 (877) 576-3636
Phone: (510) 576-8800
Fax: (510) 576-8798

 

Bio-Techne

19 Barton Lane  
Abingdon Science Park
Abingdon
OX14 3NB
United Kingdom
Phone 2: +44 1235 529449
Fax: +44 1235 533420

 

Advanced Cell Diagnostics China

20F, Tower 3,
Raffles City Changning Office,
1193 Changning Road, Shanghai 200051

021-52293200
info.cn@bio-techne.com
Web: www.acdbio.com/cn

For general information: Info.ACD@bio-techne.com
For place an order: order.ACD@bio-techne.com
For product support: support.ACD@bio-techne.com
For career opportunities: hr.ACD@bio-techne.com